People · Operator
Named in public records as an officer, director or promoter · active 2008–2015 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2008 |
| Viveve Medical, Inc. | — | Biotechnology | Series A | $41.5M | $12.3M | 2015 |
| Revascular Therapeutics Inc | — | Other | Series A | $25.8M | $109.5M | 2008 |
| Viveve, Inc. | — | Other | Seed | $5.5M | $74.4M | 2009 |
Carl Simpson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Simpson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brigitte Smith | 2 | 5 |
| Andrew Schwab | 1 | 16 |
| John Brooks | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Eric Kim | 1 | 7 |
| Peter Fitzgerald | 1 | 6 |
| Steve Salmon | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| Arlene Morris | 1 | 5 |
| Michael Hoey | 1 | 4 |
| J.C. MacRae | 1 | 3 |
| Daniel Janney | 1 | 3 |
| Michael Lynn | 1 | 3 |
| A. Barr Dolan | 1 | 3 |
| James Atkinson | 1 | 3 |
| Steven Basta | 1 | 3 |
| Geoff Brooke | 1 | 2 |
| Gregory W. Mann | 1 | 2 |
| R. King Nelson | 1 | 2 |
| Daniel S Janney | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.